Evidence map›Paper›PMID 27130679›Full record

ArticleIn vitro cellular & developmental biology. Animal2016

Establishment of a new immortalized human corneal epithelial cell line (iHCE-NY1) for use in evaluating eye irritancy by in vitro test methods.

Naoki Yamamoto, Yoshinao Kato, Atsushi Sato, Noriko Hiramatsu, Hiromi Yamashita, Mahito Ohkuma, Ei-Ichi Miyachi, Masayuki Horiguchi, Koji Hirano, Hajime Kojima

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Establishment of primary bovine intestinal epithelial cell culture and clone method.In vitro cellular & developmental biology. Animal · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Naoki YamamotoLaboratory of Molecular Biology, Fujita Health University Institute of Joint Research, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan. naokiy@fujita-hu.ac.jp.
Yoshinao KatoResearch Laboratories, Nippon Menard Cosmetic Co., Ltd, 2-7 Torimi-cho, Nishi-ku, Nagoya, Aichi, 451-0071, Japan.
Atsushi SatoResearch Laboratories, Nippon Menard Cosmetic Co., Ltd, 2-7 Torimi-cho, Nishi-ku, Nagoya, Aichi, 451-0071, Japan.
Noriko HiramatsuLaboratory of Molecular Biology, Fujita Health University Institute of Joint Research, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Hiromi YamashitaLaboratory of Molecular Biology, Fujita Health University Institute of Joint Research, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Mahito OhkumaDepartment of Physiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Ei-Ichi MiyachiDepartment of Physiology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Masayuki HoriguchiDepartment of Ophthalmology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Koji HiranoDepartment of Ophthalmology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi, 470-1192, Japan.
Hajime KojimaJapanese Center for the Validation of Alternative Methods (JaCVAM), Division of Pharmacology, Biological Safety Research Center, National Institute of Health Sciences, 1-18-1, Kamiyouga, Setagaya-ku, Tokyo, 158-8501, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vitro test methods that use human corneal epithelial cells to evaluate the eye irritation potency of chemical substances do not use human corneal epithelium because it has been difficult to maintain more than four passages. In this study, we make a new cell line comprising immortalized human corneal epithelial cells (iHCE-NY1). The IC50 of iHCE-NY1 cells is slightly higher than that of Statens Seruminstitut Rabbit Cornea (SIRC) cells, which are currently used in some in vitro test methods. CDKN1A in iHCE-NY1 cells was used as a marker of gene expression to indicate cell cycle activity. This enabled us to evaluate cell recovery characteristics at concentrations lower than the IC50 of cytotoxic tests.

Indexed as

AnimalsCell CycleCell LineCorneaCyclin-Dependent Kinase Inhibitor p21Epithelial CellsEpithelium, CornealHumansIn Vitro TechniquesRabbitsCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21CDKN1ACorneal epitheliumEye irritationIn vitro modelSIRC cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.